27th April 2020
Pamir Law Group
On 31 March 2020, China issued the “Notice Regarding Orderly Development of Medical Goods Exports applicable to the exports of Private Protective Equipment (“PPE”)”, effective 1 April 2020 (the “Notice”). MSI's Taiwan law member Pamir Law Group provides further information.
The Notice is intended to insure the quality of PPE by requiring that Chinese manufacturers of PPE have proper certifications by the State Food and Drug Administration (“SFDA”) and that the manufacturers be listed in the national medical products registry maintained by the SFDA.
The PPE categories covered include the following types of products for fighting coronavirus which require verification:
Special Goods”), and therefore require an Export Health and Quarantine Permit (“EHQP”) issued by the SFDA for export.
The exporter must provide the following documents before shipping to the customs office, which then coordinates with the SFDA officials to verify the contents:
The SFDA will render a decision on the EHQP to the manufacturer within 20 working days.
Download the full article on: New export requirements for ‘PPE’ in China
Global accountancy alliance appoints EY business leader https://t.co/V6S6JCpcPE
Thank you for including our news on the appointment of @AndrewDLeck as the new CEO of @MSI_Global https://t.co/JyAft1NCvx
Thank you for covering the news on the appointment of @AndrewDLeck as MSI's new CEO @AccountsTodayUK https://t.co/g23pEZwWLu